The Japanese Ministry of Health, Labor and Welfare has decided to add generic drugs to the National Health Insurance drug price list twice a year to promote use of generic drugs from this fiscal year (2007). The move was approved at the Chuikyo (Central Social Insurance Medical Council) meeting on April 18.
Although generic drugs have been listed once a year so far, the status survey on the use of copycat medicines, which tried to verify the results of the 2006 medical fee revision (Marketletter February12), showed that only 5.7% of the total prescriptions which allow a physician to check in "an approval column" for generic substitution available, actually made the doctor change branded products to generic drugs. "Signed" by a doctor in the approved column accounted for 17.1% of total prescriptions, reports the Marketletter's Tokyo correspondent.
Some Chuikyo members call for four times a year listing
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze